Director, R&D Portfolio Strategy & Analytics

Gsk; England; On-site; GBP 140,000 - 190,000; Full time

Job summary

GSK remains committed to bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our strong performance momentum to increase our impact on health globally.

Our Ahead Together strategy centers on early intervention to prevent disease and strengthen healthcare systems. Director, Portfolio Management partners with the Head of Portfolio Decision Sciences to support the RI&I portfolio across the R&D lifecycle, including ROI/NPV analyses, and to

Responsibilities

• Guiding pipeline project teams across the R&D lifecycle (from preclinical to late-stage clinical development, and including business development) through strategic decisions and economic analyses (e.g. eliciting the probability of success, assessing the economics [ROI and NPV] of different project development options), facilitating team decision making and option evaluation, and bridging portfolio-and project-level considerations between senior leaders and teams
• Working with pipeline project teams to provide objective individual project assessments for R&D investment decisions at RI&I RU board, other Research Unit R&D governance and the Portfolio Investment Board (PIB)
• Providing specific recommendation(s) to investment body chair(s) on the opportunities being assessed, based on rigorous analyses of options, value-risk assessment, clear delineation of where risk is discharged, and how to optimise use of resources and capabilities
• Leading portfolio-or indication-level assessments to enable senior GSK leaders to make portfolio prioritisation and investment decisions, highlighting trade‑offs based upon multiple factors (including scientific, clinical, commercial, strategic, operational, and financial)
• Bringing the external lens to portfolio and investment decisions, applying an equity analyst mindset to assess our assets as the market would by testing valuation assumptions, PTRS and peak sales against sell-side and competitor benchmarks
• Supporting the biannual dynamic Portfolio Review (dPR) process for RI&I, ensuring refreshed pipeline project views and surfacing of new investment opportunities, and informing the RI&I portfolio prioritisation to optimise how functions deploy resources
• Collaborating with colleagues across the portfolio management team, the broader finance group, the Research Unit leaders, and partners in strategy, project management, operations, etc to recommend areas of short-term and longer-term focus from a disease area, indication, modality perspective

Job description

GSK remains committed to bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our strong performance momentum to increase our impact on health globally.

Our Ahead Together strategy centers on early intervention to prevent disease and strengthen healthcare systems. Director, Portfolio Management partners with the Head of Portfolio Decision Sciences to support the RI&I portfolio across the R&D lifecycle, including ROI/NPV analyses, and to